🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Biological DMARDs

Found 137 matching trials

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

N/A

Premature Endothelial Dysfunction is present in patients with early rheumat...

Status

Completed

Location

Orrin M. Troum, MD and Medical Associates

Start Date

2011-12

Trial ID

NCT01499732

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

PHASE3

This randomized, double-blind, parallel group study compares the efficacy a...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01194414

Treatments Being Tested

tocilizumab SC tocilizumab IV placebo to tocilizumab SC placebo to tocilizumab IV Disease-modifying antirheumatic drugs (DMARDs)

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

PHASE4

A Canadian study to evaluate early use of adalimumab after methotrexate fai...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01162421

Treatments Being Tested

adalimumab Methotrexate

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

PHASE3

The purpose of this study is to evaluate the efficacy and safety of deucrav...

Status

Active Not Recruiting

Location

Local Institution - 0197

Start Date

2021-07-13

Trial ID

NCT04908202

Treatments Being Tested

Deucravacitinib Placebo

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

N/A

The current study will assess the real - life effectiveness of adalimumab i...

Status

Completed

Location

Rheumatology Clinic /ID# 54768

Start Date

2011-06-29

Trial ID

NCT01387802

A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs

N/A

The purpose of this Italian multicenter study is to collect prospective cli...

Status

Completed

Location

ASST Spedali Civili Brescia

Start Date

2017-06-09

Trial ID

NCT03131661

A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

PHASE3

This open-label study will evaluate the efficacy and safety of tocilizumab ...

Status

Completed

Location

Aberdeen Royal Infirmary

Start Date

2014-03-04

Trial ID

NCT02046603

Treatments Being Tested

Tocilizumab DMARDs Oral Corticosteroids Methotrexate

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

N/A

This is a secondary structured database observational study conducted in Rh...

Status

Completed

Location

Pfizer

Start Date

2022-10-10

Trial ID

NCT05572567

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.

N/A

Different classes of biological targeted therapies (b-DMARDs) are available...

Status

Unknown

Location

Division of Rheumatology

Start Date

2019-10-03

Trial ID

NCT05767814

Treatments Being Tested

Phenotyping of synovial immune and stromal cells

Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis

N/A

Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the con...

Status

Unknown

Location

University of Ghent, Department of Rheumatology

Start Date

2013-04

Trial ID

NCT01834157

Previous Next